Description
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
Product Unit Size | Cost | Quantity | Stock |
---|
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
Cas No. | 1170354-22-9 |
---|---|
Purity | ≥95% |
Formula | C28H22F2O6 |
Formula Wt. | 492.47 |
Chemical Name | (1E,6E)-1,7-bis-(4-hydroxy-3-methosyphenyl) hepta-1,6-diene [4(3,4-difluorobenzaldehyde)]-3,5-dione |
IUPAC Name | (1E,6E)-4-[(3,4-difluorophenyl)methylidene]-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione |
Synonym | Difluorobenzocurcumin, 3,4-Difluorobenzocurcumin, CDF |
Melting Point | 214-217°C |
Solubility | DMSO, 110mg/mL |
Appearance | Bright Yellow Powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures | |
Okuda KS, Ng MF, Ruslan NF, et al. 3,4-Difluorobenzocurcumin inhibits Vegfc-Vegfr3-Erk signalling to block developmental lymphangiogenesis in zebrafish. Pharmaceuticals (Basel). 2021 Jun 26;14(7):614. PMID: 34206901.
Sesquiterpene lactone derived from Artemesia.
Thiol derivative, antioxidant.
Prodrug
mGluR5 positive modulator.
Smoothened agonist.
Prenylflavinoid, derivative of xanthohumol foun...
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Antimicrobial peptide.
B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit...
Synthetic steroid; glucocorticoid agonist.
Endogenous peptide hormone inolved in gastric e...
JAK3 and EGFR inhibitor.
Estradiol metabolite.
Thienylbutyl ITC analog.
Monoterpene; nAChR antagonist.
CDK4/6 inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
p110α PI3K and mTOR inhibitor.
Purine derivative; CDK inhibitor.
Inhibitor of VEGFR1/2/3.